Cargando…

Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?

The interest in cannabis-based products for the treatment of refractory epilepsy has skyrocketed in recent years. Marijuana and other cannabis products with high content in Δ(9) - tetrahydrocannabinol (THC), utilized primarily for recreational purposes, are generally unsuitable for this indication,...

Descripción completa

Detalles Bibliográficos
Autor principal:	Perucca, Emilio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Epilepsy Society 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767492/ https://www.ncbi.nlm.nih.gov/pubmed/29344464 http://dx.doi.org/10.14581/jer.17012

Ejemplares similares

New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: II. Treatments in Clinical Development
por: Perucca, Emilio, et al.
Publicado: (2023)

Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects
por: Morano, Alessandra, et al.
Publicado: (2020)

Cannabinoids and Reproduction: A Lasting and Intriguing History
por: Cacciola, Giovanna, et al.
Publicado: (2010)

Not all that glitters is gold: A guide to the critical interpretation of drug trials in epilepsy
por: Perucca, Emilio, et al.
Publicado: (2016)

The ILAE at 110—Reflections on the last decade
por: Wiebe, Samuel, et al.
Publicado: (2019)

The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids
por: Kwan Cheung, Keith A., et al.
Publicado: (2019)

Pregabalin for the management of partial epilepsy
por: Ryvlin, Philippe, et al.
Publicado: (2008)

New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System
por: Perucca, Emilio, et al.
Publicado: (2023)

Advocacy for children with epilepsy: Leveraging the WHA resolution. Advocacy Task Force, Commission of Pediatrics, International League Against Epilepsy
por: Wilmshurst, Jo M., et al.
Publicado: (2018)

Neural Stem Cells and Cannabinoids in the Spotlight as Potential Therapy for Epilepsy
por: Lourenço, Diogo M., et al.
Publicado: (2020)

Genetic Contributions to Acquired Epilepsies
por: Perucca, Piero, et al.
Publicado: (2020)

From clinical trials of antiepileptic drugs to treatment
por: Perucca, Emilio
Publicado: (2018)

Highights in the History of Epilepsy: The Last 200 Years
por: Magiorkinis, Emmanouil, et al.
Publicado: (2014)

Clinically Relevant Interactions Between Ritonavir-Boosted Nirmatrelvir and Concomitant Antiseizure Medications: Implications for the Management of COVID-19 in Patients with Epilepsy
por: Wanounou, Maor, et al.
Publicado: (2022)

Management of post‐traumatic epilepsy: An evidence review over the last 5 years and future directions
por: Piccenna, Loretta, et al.
Publicado: (2017)

Do Cannabinoids Confer Neuroprotection Against Epilepsy? An Overview
por: Capasso, Anna
Publicado: (2017)

The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids—A Systematic Review
por: Cohen, Koby, et al.
Publicado: (2018)

A Survey on Cannabinoid Treatment of Pediatric Epilepsy Among Neuropediatricians in Scandinavia and Germany
por: Klingenberg, Claus, et al.
Publicado: (2020)

Cannabinoids in Audiogenic Seizures: From Neuronal Networks to Future Perspectives for Epilepsy Treatment
por: Lazarini-Lopes, Willian, et al.
Publicado: (2021)

Applications for Deep Learning in Epilepsy Genetic Research
por: Zeibich, Robert, et al.
Publicado: (2023)

Hippocampal expression of the cannabinoid receptor type 1 in canine epilepsy
por: Kostic, D., et al.
Publicado: (2023)

Cannabinoids for the Treatment of Dermatologic Conditions
por: Sivesind, Torunn E., et al.
Publicado: (2022)

Roles of Cannabinoids in Melanoma: Evidence from In Vivo Studies
por: Bachari, Ava, et al.
Publicado: (2020)

Clinical Evidence of Cannabinoids in Migraine: A Narrative Review
por: Lo Castro, Flavia, et al.
Publicado: (2022)

Editorial: Challenges and Conundrums in Cannabinoid-Based Treatments for Epilepsy Syndromes and Associated Neurobehavioral Comorbidities
por: Gómez-Nieto, Ricardo, et al.
Publicado: (2021)

The 50th anniversary of the Italian League against epilepsy (Lega Italiana Contro l’Epilessia)()
por: Tassi, Laura, et al.
Publicado: (2022)

Epilepsy priorities in Europe: A report of the ILAE‐IBE Epilepsy Advocacy Europe Task Force
por: Baulac, Michel, et al.
Publicado: (2015)

Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists
por: Butler, Helen, et al.
Publicado: (2009)

Cannabinoids and Cannabinoid Receptors: The Story so Far
por: Shahbazi, Fred, et al.
Publicado: (2020)

Use of Cannabis and Cannabinoids for Treatment of Cancer
por: Cherkasova, Viktoriia, et al.
Publicado: (2022)

Swimming up a Sewer: A Hard Look at 'Last Exit'
por: Fox, Richard
Publicado: (1968)

Epigenomic and Other Evidence for Cannabis-Induced Aging Contextualized in a Synthetic Epidemiologic Overview of Cannabinoid-Related Teratogenesis and Cannabinoid-Related Carcinogenesis
por: Reece, Albert Stuart, et al.
Publicado: (2022)

Cannabinoid Delivery Systems for Pain and Inflammation Treatment
por: Bruni, Natascia, et al.
Publicado: (2018)

Synthetic cannabinoids
por: Bilici, Rabia
Publicado: (2014)

The biosynthesis of the cannabinoids
por: Tahir, M. Nazir, et al.
Publicado: (2021)

Pharmacogenetics of Cannabinoids
por: Hryhorowicz, Szymon, et al.
Publicado: (2017)

Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer
por: Sharafi, Golnaz, et al.
Publicado: (2019)

Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases
por: Kienzl, Melanie, et al.
Publicado: (2020)

Laser interstitial thermal therapy for the treatment of epilepsy: evidence to date
por: Shukla, Navika D, et al.
Publicado: (2017)

Endo-cannabinoids system and the toxicity of cannabinoids with a biotechnological approach
por: Niaz, Kamal, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r5su9onge6m3sebl65qbb8pknm